NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased ERBA Diagnostics, Inc. (NYSEMKT: ERB) securities between April 14, 2014 and November 20, 2015.
Click here to learn about the case: http://docs.wongesq.com/ERB-Info-Request-Form-1032. There is no cost or obligation to you.
The complaint alleges that, throughout the Class Period, Defendants issued materially false and misleading statements and/or failed to disclose that: (1) ERBA’s accounting of intercompany transactions among its subsidiaries, including its consolidated financial statements, were improper and had an impact on reported assets and liabilities; (2) ERBA lacked adequate controls over financial reporting; (3) ERBA’s financial statements during the Class Period were materially false and misleading; and (4) as a result, Defendants’ statements about ERBA’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in ERBA you have until February 1, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email firstname.lastname@example.org, by telephone at 212.425.1140, or visit http://docs.wongesq.com/ERB-Info-Request-Form-1032.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.